Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 36,560 shares at $16.01 ($589K) on 2023-06-13, disclosed to the SEC on 2023-06-15.
Scheduled sale ($589k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.01 | 5,628 | $90K | 15.3% |
| 2 | $16.01 | 5,628 | $90K | 15.3% |
| 3 | $16.45 | 120 | $2K | 0.3% |
| 4 | $16.15 | 12,592 | $203K | 34.5% |
| 5 | $16.15 | 12,592 | $203K | 34.5% |
| Total | $16.11 avg | 36,560 |
| $589K |
| 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |